Brickell Biotech, Inc. company info

CIK 819050
IRS Number 930948554
State of incorporation DE
Business address 5777 CENTRAL AVENUE
Mail address 5777 CENTRAL AVENUE

Short summary

Brickell Biotech, Inc. is a Colorado company, with head office located at 5777 Central Avenue Boulder, Colorado 80301. In 2018 the company owned a total of 42.70 million USD worth of assets, including 42.70 million USD worth of current assets. 2011 was the year when the company amassed the most assets.

Brickell Biotech, Inc. Income Statement

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Research and development 23.4519.6917.9817.3414.5611.4711.0610.3614.3912.33
Operating Expenses 41.2739.9337.8440.9539.0731.8430.35
Operating Income (Loss) -28.59-31.22-7.82-23.43-31.35-16.63-9.40-9.18-13.39-19.65
Interest expense 0.00
Income Tax Expense (Benefit) 0000000
Net income -28.56-30.39-7.28-22.90-31.24-16.49-9.24-8.97-12.96-16.25

Brickell Biotech, Inc. Balance Sheet

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Cash and cash equivalents 23.7612.3424.6165.7245.0331.7919.675.234.6110.0710.81
Available-for-sale Securities, Current 12.3026.1019.4114.6218.8927.7527.2541.8338.27
Property, Plant and Equipment, Gross 27.1427.6526.0825.5625.4725.1925.053.27
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 20.9122.3722.1422.9223.6024.0124.453.17
Available-for-sale Securities, Noncurrent 30000
Intangible Assets, Net (Excluding Goodwill) 3.092.862.741.99
Other Assets, Noncurrent
Total assets 56.71109.7279.2961.5952.3845.8550.7856.7742.70
Current assets 40.8998.5969.5854.0746.4440.9746.5253.7142.70
Accounts payable 0.491.300.670.560.460.620.360.54
Total current liabilities 5.675.066.063.794.553.3110.983.181.16
Common Stock, Value, Issued 0.720.860.870.880.910.
Retained Earnings (Accumulated Deficit) -334.86-332.66-367.10-386.67-402.25-408.58-419.92-436.95-449.07
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.610.

Brickell Biotech, Inc. Cash Flow

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Net income -28.56-30.39-7.28-22.90-31.24-16.49-9.24-8.97-12.96-16.25
Depreciation and amortization 1.601.400.900.900.600.10
Depreciation 21.601.601.601.40
Amortization of Intangible Assets 0.800.700.400.400.
Depreciation and amortization 2.632.812.301.982.211.661.161.120.790.15
Deferred revenue 0.28-1.990.100.050-
Net Cash Provided by (Used in) Operating Activities -21.45-28.23-3.85-17.57-29.80-8.39-8.60-14.45
Payments to Acquire Property, Plant, and Equipment 0.340.350.260.650.330.
Payments to Acquire Intangible Assets 0.320.410.410.410.410.270.0500
Net Cash Provided by (Used in) Investing Activities -9.2812.51-4.83-26.9925.14-7.67-5.291.28
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -26.9925.14-12.430.01-7.67-5.29
Proceeds from Issuance of Common Stock 33.0437.260.2148.930.823.930.007.76
Net Cash Provided by (Used in) Financing Activities 32.8537.170.0648.680.337.7430.550
Cash and Cash Equivalents, Period Increase (Decrease) 2.1121.45-8.624.46-4.32-18.37-7.02-8.38